Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies

• Alexis Moscoso,
• Melissa C. Wren,
• Tammaryn Lashley,
• Erik Arstad,
• Melissa E. Murray,
• Nick C. Fox,
• Kerstin Sander,
• Michael Schöll

Affiliations

Alexis Moscoso

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg

Melissa C. Wren

Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London

Tammaryn Lashley

Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London

Erik Arstad

Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London

Melissa E. Murray

Department of Neuroscience, Mayo Clinic

Nick C. Fox

Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London

Kerstin Sander

Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London

Michael Schöll

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg